candesartan has been researched along with Sclerosis in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Sclerosis: A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishimitsu, T | 1 |
| Honda, T | 1 |
| Ohno, E | 1 |
| Furukata, S | 1 |
| Sudo, Y | 1 |
| Nakano, N | 1 |
| Takahashi, T | 1 |
| Ono, H | 1 |
| Matsuoka, H | 1 |
| Nakamura, T | 1 |
| Honma, H | 1 |
| Ikeda, Y | 1 |
| Kuroyanagi, R | 1 |
| Takano, H | 1 |
| Obata, J | 1 |
| Sato, T | 1 |
| Kimura, H | 1 |
| Yoshida, Y | 1 |
| Tamura, K | 1 |
2 other studies available for candesartan and Sclerosis
| Article | Year |
|---|---|
Year-long antihypertensive therapy with candesartan completely prevents development of cardiovascular organ injuries in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; D | 2010 |
Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cereb | 1994 |